ALSO NOTED: Genaera touts Phase II results; Genentech reports big increase in profits; Predicant lines up debt financing; and m

> Genaera reported that a Phase II trial of Evizon with Visudyne demonstrated its safety and vision stabilization for patients with wet, age-related macular degeneration. Release

> The phenomenal success of Avastin and Herceptin for cancer has helped swell Genentech's quarterly net income by 56 percent. Article

> Predicant Biosciences has lined up $7.5 million of debt financing from Hercules Technology Growth Capital. Release

> Boston-based Surface Logix said that an early-stage trial of SLx-2101 for sexual dysfunction shows it was safe and well tolerated and demonstrated signs of pharmacokinetic activity. Release

And Finally… Although still relatively rare in the US, the incidence of liver cancer is rising fast. Article